Shopping Cart 0
Cart Subtotal
AED 0

Global Capecitabine Market Analysis 2013-2018 and Forecast 2019-2024

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 10937

Access to Printed Report; No Soft Copy
Print Option: N/A
Copy Option: N/A
Deliverable Format : Printed Publication/ Book by Post

Hard Copy License
AED 11671

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 21873

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 21873
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

Snapshot

Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.

The global Capecitabine market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Capecitabine by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

500 mg

150 mg

Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):

Teva

Roche

Mylan

Hikma

Hengrui Medicine

Cipla

Reliance Group

Hetero

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

Breast Cancer

Colorectal cancer

Stomach Cancer

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

READ MORE

Table Of Content

Scope

Table of Contents

1 Industry Overview

1.1 Capecitabine Industry

1.1.1 Overview

1.1.2 Development of Capecitabine

1.2 Market Segment

1.2.1 Upstream

1.2.2 Downstream

1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

2.1 Policy

2.2 Economics

2.3 Sociology

2.4 Technology

3 Capecitabine Market by Type

3.1 By Type

3.1.1 500 mg

3.1.2 150 mg

3.2 Market Size

3.3 Market Forecast

4 Major Companies List

4.Capecitabine Teva (Company Profile, Sales Data etc.)

4.2 Roche (Company Profile, Sales Data etc.)

4.3 Mylan (Company Profile, Sales Data etc.)

4.4 Hikma (Company Profile, Sales Data etc.)

4.5 Hengrui Medicine (Company Profile, Sales Data etc.)

4.6 Cipla (Company Profile, Sales Data etc.)

4.7 Reliance Group (Company Profile, Sales Data etc.)

4.8 Hetero (Company Profile, Sales Data etc.)

5 Market Competition

5.1 Company Competition

5.2 Regional Market by Company

6 Demand by End Market

6.1 Demand Situation

6.1.1 Demand in Breast Cancer

6.1.2 Demand in Colorectal cancer

6.1.3 Demand in Stomach Cancer

6.2 Regional Demand Comparison

6.3 Demand Forecast

7 Region Operation

7.1 Regional Production

7.2 Regional Market

7.3 by Region

7.3.1 North America

7.3.1.1 Overview

7.3.1.2 by Country (U.S., Canada, Mexico)

7.3.2 Europe

7.3.2.1 Overview

7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)

7.3.3 Asia-Pacific

7.3.3.1 Overview

7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)

7.3.4 South America

7.3.4.1 Overview

7.3.4.2 by Country (Brazil, Argentina etc.)

7.3.5 Middle East & Africa

7.3.5.1 Overview

7.3.5.2 by Country (Saudi Arabia, South Africa etc.)

7.4 Regional Import & Export

7.5 Regional Forecast

8 Marketing & Price

8.1 Price and Margin

8.1.1 Price Trends

8.1.2 Factors of Price Change

8.1.3 Manufacturers Gross Margin Analysis

8.2 Marketing Channel

9 Research Conclusion


List Of Figure

Figure Global Capecitabine Market Growth 2013-2018, by Type, in USD Million

Figure Global Capecitabine Market Growth 2013-2018, by Type, in Volume

Figure North America Capecitabine Market Concentration, in 2018

Figure Europe Capecitabine Market Market Concentration, in 2018

Figure Asia-Pacific Capecitabine MMarket Concentration, in 2018

Figure South America Capecitabine Market Concentration, in 2018

Figure Middle East & Africa Capecitabine Market Concentration, in 2018

Figure Capecitabine Demand in Breast Cancer, 2013-2018, in USD Million

Figure Capecitabine Demand in Breast Cancer, 2013-2018, in Volume

Figure Capecitabine Demand in Colorectal cancer, 2013-2018, in USD Million

Figure Capecitabine Demand in Colorectal cancer, 2013-2018, in Volume

Figure Capecitabine Demand in Stomach Cancer, 2013-2018, in USD Million

Figure Capecitabine Demand in Stomach Cancer, 2013-2018, in Volume

Figure North America Capecitabine Market Size and Growth 2013-2018, in USD Million

Figure North America Capecitabine Market Size and Growth 2013-2018, in Volume

Figure Europe Capecitabine Market Size and Growth 2013-2018, in USD Million

Figure Europe Capecitabine Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific Capecitabine Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Capecitabine Market Size and Growth 2013-2018, in Volume

Figure South America Capecitabine Market Size and Growth 2013-2018, in USD Million

Figure South America Capecitabine Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa Capecitabine Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Capecitabine Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview


List Of Table

Table Upstream Segment of Capecitabine

Table Application Segment of Capecitabine

Table Global Capecitabine Market 2013-2024, by Application, in USD Million

Table Major Company List of 500 mg

Table Major Company List of 150 mg

Table Global Capecitabine Market 2013-2018, by Type, in USD Million

Table Global Capecitabine Market 2013-2018, by Type, in Volume

Table Global Capecitabine Market Forecast 2019-2024, by Type, in USD Million

Table Global Capecitabine Market Forecast 2019-2024, by Type, in Volume

Table Teva Overview List

Table Capecitabine Business Operation of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Roche Overview List

Table Capecitabine Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Mylan Overview List

Table Capecitabine Business Operation of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Hikma Overview List

Table Capecitabine Business Operation of Hikma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Hengrui Medicine Overview List

Table Capecitabine Business Operation of Hengrui Medicine (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Cipla Overview List

Table Capecitabine Business Operation of Cipla (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Reliance Group Overview List

Table Capecitabine Business Operation of Reliance Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Hetero Overview List

Table Capecitabine Business Operation of Hetero (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Capecitabine Sales Revenue 2013-2018, by Company, in USD Million

Table Global Capecitabine Sales Revenue Share, by Company, in USD Million

Table Global Capecitabine Sales Volume 2013-2018, by Company, in Volume

Table Global Capecitabine Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Capecitabine Demand Forecast 2019-2024, by Application, in USD Million

Table Capecitabine Demand Forecast 2019-2024, by Application, in Volume

Table Capecitabine Production 2013-2018, by Region, in USD Million

Table Capecitabine Production 2013-2018, by Region, in Volume

Table Global Capecitabine Market 2013-2018, by Region, in USD Million

Table Global Capecitabine Market Share 2013-2018, by Region, in USD Million

Table Global Capecitabine Market 2013-2018, by Region, in Volume

Table Global Capecitabine Market Share 2013-2018, by Region, in Volume

Table North America Capecitabine Market Size 2013-2018, by Country, in USD Million

Table North America Capecitabine Market Size 2013-2018, by Country, in Volume

Table Europe Capecitabine Market Size 2013-2018, by Country, in USD Million

Table Europe Capecitabine Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific Capecitabine Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Capecitabine Market Size 2013-2018, by Country, in Volume

Table South America Capecitabine Market Size 2013-2018, by Country, in USD Million

Table South America Capecitabine Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa Capecitabine Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Capecitabine Market Size 2013-2018, by Country, in Volume

Table Capecitabine Market Forecast 2019-2024, by Region, in USD Million

Table Capecitabine Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

Licence Rights

"Single User License
allow one user to read, print, and edit the report

Enterprise License
allow all employees within client's company, to read, print, edit the report"

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Snapshot

Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.

The global Capecitabine market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Capecitabine by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

500 mg

150 mg

Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):

Teva

Roche

Mylan

Hikma

Hengrui Medicine

Cipla

Reliance Group

Hetero

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

Breast Cancer

Colorectal cancer

Stomach Cancer

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

READ MORE

Scope

Table of Contents

1 Industry Overview

1.1 Capecitabine Industry

1.1.1 Overview

1.1.2 Development of Capecitabine

1.2 Market Segment

1.2.1 Upstream

1.2.2 Downstream

1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

2.1 Policy

2.2 Economics

2.3 Sociology

2.4 Technology

3 Capecitabine Market by Type

3.1 By Type

3.1.1 500 mg

3.1.2 150 mg

3.2 Market Size

3.3 Market Forecast

4 Major Companies List

4.Capecitabine Teva (Company Profile, Sales Data etc.)

4.2 Roche (Company Profile, Sales Data etc.)

4.3 Mylan (Company Profile, Sales Data etc.)

4.4 Hikma (Company Profile, Sales Data etc.)

4.5 Hengrui Medicine (Company Profile, Sales Data etc.)

4.6 Cipla (Company Profile, Sales Data etc.)

4.7 Reliance Group (Company Profile, Sales Data etc.)

4.8 Hetero (Company Profile, Sales Data etc.)

5 Market Competition

5.1 Company Competition

5.2 Regional Market by Company

6 Demand by End Market

6.1 Demand Situation

6.1.1 Demand in Breast Cancer

6.1.2 Demand in Colorectal cancer

6.1.3 Demand in Stomach Cancer

6.2 Regional Demand Comparison

6.3 Demand Forecast

7 Region Operation

7.1 Regional Production

7.2 Regional Market

7.3 by Region

7.3.1 North America

7.3.1.1 Overview

7.3.1.2 by Country (U.S., Canada, Mexico)

7.3.2 Europe

7.3.2.1 Overview

7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)

7.3.3 Asia-Pacific

7.3.3.1 Overview

7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)

7.3.4 South America

7.3.4.1 Overview

7.3.4.2 by Country (Brazil, Argentina etc.)

7.3.5 Middle East & Africa

7.3.5.1 Overview

7.3.5.2 by Country (Saudi Arabia, South Africa etc.)

7.4 Regional Import & Export

7.5 Regional Forecast

8 Marketing & Price

8.1 Price and Margin

8.1.1 Price Trends

8.1.2 Factors of Price Change

8.1.3 Manufacturers Gross Margin Analysis

8.2 Marketing Channel

9 Research Conclusion


List Of Figure

Figure Global Capecitabine Market Growth 2013-2018, by Type, in USD Million

Figure Global Capecitabine Market Growth 2013-2018, by Type, in Volume

Figure North America Capecitabine Market Concentration, in 2018

Figure Europe Capecitabine Market Market Concentration, in 2018

Figure Asia-Pacific Capecitabine MMarket Concentration, in 2018

Figure South America Capecitabine Market Concentration, in 2018

Figure Middle East & Africa Capecitabine Market Concentration, in 2018

Figure Capecitabine Demand in Breast Cancer, 2013-2018, in USD Million

Figure Capecitabine Demand in Breast Cancer, 2013-2018, in Volume

Figure Capecitabine Demand in Colorectal cancer, 2013-2018, in USD Million

Figure Capecitabine Demand in Colorectal cancer, 2013-2018, in Volume

Figure Capecitabine Demand in Stomach Cancer, 2013-2018, in USD Million

Figure Capecitabine Demand in Stomach Cancer, 2013-2018, in Volume

Figure North America Capecitabine Market Size and Growth 2013-2018, in USD Million

Figure North America Capecitabine Market Size and Growth 2013-2018, in Volume

Figure Europe Capecitabine Market Size and Growth 2013-2018, in USD Million

Figure Europe Capecitabine Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific Capecitabine Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Capecitabine Market Size and Growth 2013-2018, in Volume

Figure South America Capecitabine Market Size and Growth 2013-2018, in USD Million

Figure South America Capecitabine Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa Capecitabine Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Capecitabine Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview


List Of Table

Table Upstream Segment of Capecitabine

Table Application Segment of Capecitabine

Table Global Capecitabine Market 2013-2024, by Application, in USD Million

Table Major Company List of 500 mg

Table Major Company List of 150 mg

Table Global Capecitabine Market 2013-2018, by Type, in USD Million

Table Global Capecitabine Market 2013-2018, by Type, in Volume

Table Global Capecitabine Market Forecast 2019-2024, by Type, in USD Million

Table Global Capecitabine Market Forecast 2019-2024, by Type, in Volume

Table Teva Overview List

Table Capecitabine Business Operation of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Roche Overview List

Table Capecitabine Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Mylan Overview List

Table Capecitabine Business Operation of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Hikma Overview List

Table Capecitabine Business Operation of Hikma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Hengrui Medicine Overview List

Table Capecitabine Business Operation of Hengrui Medicine (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Cipla Overview List

Table Capecitabine Business Operation of Cipla (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Reliance Group Overview List

Table Capecitabine Business Operation of Reliance Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Hetero Overview List

Table Capecitabine Business Operation of Hetero (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Capecitabine Sales Revenue 2013-2018, by Company, in USD Million

Table Global Capecitabine Sales Revenue Share, by Company, in USD Million

Table Global Capecitabine Sales Volume 2013-2018, by Company, in Volume

Table Global Capecitabine Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Capecitabine Demand Forecast 2019-2024, by Application, in USD Million

Table Capecitabine Demand Forecast 2019-2024, by Application, in Volume

Table Capecitabine Production 2013-2018, by Region, in USD Million

Table Capecitabine Production 2013-2018, by Region, in Volume

Table Global Capecitabine Market 2013-2018, by Region, in USD Million

Table Global Capecitabine Market Share 2013-2018, by Region, in USD Million

Table Global Capecitabine Market 2013-2018, by Region, in Volume

Table Global Capecitabine Market Share 2013-2018, by Region, in Volume

Table North America Capecitabine Market Size 2013-2018, by Country, in USD Million

Table North America Capecitabine Market Size 2013-2018, by Country, in Volume

Table Europe Capecitabine Market Size 2013-2018, by Country, in USD Million

Table Europe Capecitabine Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific Capecitabine Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Capecitabine Market Size 2013-2018, by Country, in Volume

Table South America Capecitabine Market Size 2013-2018, by Country, in USD Million

Table South America Capecitabine Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa Capecitabine Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Capecitabine Market Size 2013-2018, by Country, in Volume

Table Capecitabine Market Forecast 2019-2024, by Region, in USD Million

Table Capecitabine Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

"Single User License
allow one user to read, print, and edit the report

Enterprise License
allow all employees within client's company, to read, print, edit the report"

To know more information on Purchase by Section, please send a mail to support@kenresearch.com